¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"endocrine cell of pineal gland"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® adrenal gland ÇÑ±Û ºÎ½Å
¼³¸í   
  ÄáÆÏÀ§¿¡ Á¸ÀçÇϴ ÇǶó¹Ô¸ð¾çÀÇ ±¸Á¶¹°. °ÑÁú°ú ¼ÓÁú·Î µÇ¾î ÀÖÀ¸¸ç È£¸£¸óÀÇ ºÐºñ°¡ ÁÖ¿ªÇÒÀÌ´Ù.
  
  ºÎ½Å
¿µ¹® gland ÇÑ±Û »ù
¼³¸í   
  ÀÚ½ÅÀÇ ´ë»ó¿¡ Çʿ䰡 ¾ø´Â ¹°ÁúÀ» ¸¸µé¾î ºÐºñÇϴ ¼¼Æ÷°¡ ¸ð¿©¼­ ¸¸µå´Â ±¸Á¶. Áкñ¹°À» Á¦Á¶Çϴ ¼¼Æ÷°¡ ¸ðÀΠ°ÍÀÌ´Ù. ¼±¿¡´Â ³»ºÐºñ»ù°ú ¿ÜºÐºñ»ùÀÇ 2°¡Áö°¡ ÀÖ´Ù. ³»ºÐºñ»ùÀ̶õ ¸ö¹ÛÀÌ ¾Æ´Ñ ³»ºÎ, Áï Á÷Á¢ Ç÷ÁßÀ¸·Î ºÐºñ¹°À» ºÐºñÇϴ »ùÀ¸·Î ÀÌ ¶§¿¡ ºÐºñµÇ´Â ¹°ÁúÀ» È£¸£¸óÀ̶ó°í ÇÑ´Ù. À̰ÍÀº ÁַΠ¸ö¾ÈÀÇ ´Ù¸¥ ¼¼Æ÷¿¡ ÀÛ¿ëÀ» ÇÏ¿© ±× ¼¼Æ÷ÀÇ ´ë»ç, ºÐ¿­ µîÀÇ º¯È­¸¦ ÃÊ·¡ÇÏ°í ¸öÀǠȯ°æÀÇ º¯È­¿¡ µû¸¥ ÀûÀÀÀ» µ½´Â ¿ªÇÒÀ» ÇÑ´Ù. ¿ÜºÐºñ»ùÀ̶õ ¸ö¹ÛÀ¸·Î °ü±¸Á¶¸¦ ÅëÇÏ¿© ºÐºñ¹°À» ³»º¸³»´Â »ùÀ» ¸»ÇÑ´Ù.
¿µ¹® prostate gland ÇÑ±Û Àü¸³»ù
¼³¸í   
  ³²¼º»ý½Ä±âÀÇ ¿ÜºÐºñ»ùÀÇ ÀÏÁ¾À¸·Î, ¹æ±¤ÀÇ ¸ñºÎºÐ°ú ¿äµµ¸¦ µÑ·¯½Î°í ÀÖ´Ù. Àü¸³»ùÀº Á¤¾×À» ¸¸µå´Â Àü¸³»ù¾×À» ºÐºñÇϸç 5°³ÀÇ ¿±À¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
¿µ¹® salivary gland ÇÑ±Û Ä§»ù, Ÿ¾×¼±
¼³¸í   
  ÀÔ ¼ÓÀ¸·Î Ä§À» ºÐºñÇϴ ¿ÜºÐºñ»ùÀ¸·Î ÀÎü¿¡´Â ¼¼ ½ÖÀǠħ»ùÀÌ Àִµ¥ ±Í¹Ø»ù, Åιػù ¹× Çô¹Ø»ùÀÌ ±×µéÀÌ´Ù. Ä§»ùÀº ºÐ·ù»óÀ¸·Î ¼ÒÈ­±â°èÅëÀÇ ÇÑ Àå±âÀ̸ç, ¼ÒÈ­°üÀÇ ÇÑ ºÎ¼Ó»ùÀ¸·Î ±¸ºÐµÈ´Ù. Çô¹Ø»ùÀº ±× ¿Ü ±¸°­ Á¡¸· ³»¿¡ »êÀçÇϰí Àִ ¼ö¸¹Àº ÀÛÀº Ä§»ù°ú °°ÀÌ ¹±Àº ¿ë¾×À» ²÷ÀÓ¾øÀÌ ºÐºñÇϰí ÀÖÁö¸¸, ±Í¹Ø»ù°ú ÅιػùÀº ÀÚ±ØÀ» ¹ÞÀ» ¶§¸¸ Ä§À» ºÐºñÇÑ´Ù.
¿µ¹® sebaceous gland ÇÑ±Û ÇǺα⸧»ù
¼³¸í   
  ÇǺÎÀÇ ÇÇÇÏÁ¶Á÷¿¡ Àִ ¿ÂºÐºñ»ù(holocrine gland)À¸·Î ÇǺΠ±â¸§À̳ª, ±× ¿Ü ±â¸§ ¼ººÐÀ» ºÐºñÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • multiple endocrine neoplasia 2
    ´Ù¹ß³»ºÐºñ»ùÁ¾¾ç2Çü
  • multiple endocrine neoplasia 3
    ´Ù¹ß³»ºÐºñ»ùÁ¾¾ç3Çü
  • accessory parotid gland
    µ¡±Í¹Ø»ù, ºÎÀÌÇϼ±
  • accessory thyroid gland
    µ¡°©»ó»ù
  • apocrine gland
    ºÎºÐºÐºñ»ù, ¾ÆÆ÷Å©¸°»ù
  • apocrine sweat gland
    ºÎºÐºÐºñ¶¡»ù, ¾ÆÆ÷Å©¸°¶¡»ù
  • areolar gland
    Á¥²ÉÆÇ»ù, À¯·û¼±
  • arytenoid gland
    ¸ð»Ô»ù, ÇÇ¿­¼±
  • acinar gland
    ²Ê¸®»ù, ¼¼¿±¼±
  • admaxillary gland
    µ¡±Í¹Ø»ù, ºÎÀÌÇϼ±
  • adrenal gland
    ºÎ½Å, ÄáÆÏÀ§»ù
  • alveolar gland
    ²Ê¸®»ù, Æ÷»ó¼±
  • anal gland
    Ç×¹®ÁÖÀ§»ù, Ç×¹®¼±
  • Bartholin¡¯s gland
    Å«Áú¾î±Í»ù, ¹Ù¸£Å縰»ù
  • bronchial gland
    ±â°üÁö»ù, ±â°üÁö¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • seromucous gland
    ÀåÁ¡¾×»ù
  • serous gland
    Àå¾×»ù
  • sublingual gland
    Çô¹Ø»ù
  • submandibular gland
    Åιػù
  • suprarenal gland
    ºÎ½Å, ÄáÆÏÀ§»ù
  • sweat gland
    ¶¡»ù
  • tarsal gland
    ´«²¨Ç®ÆÇ»ù
  • thyroid gland
    °©»ó»ù
  • urethral gland
    ¿äµµ»ù
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • cell
    ¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • amacrine cell
    ¹«Ãà»è¼¼Æ÷
  • balloon cell
    dz¼±¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • accessory thyroid gland
    µ¡°©»ó»ù, µ¡¹æÆÐ»ù
  • acinar gland
    ²Ê¸®»ù
  • admaxillary gland
    (¢¡accessory parotid gland) µ¡±Í¹Ø»ù
  • adrenal gland
    ºÎ½Å, ÄáÆÏÀ§»ù
  • alveolar gland
    ²Ê¸®»ù
  • anal gland
    (¢¡circumanal gland) Ç×¹®ÁÖÀ§»ù
  • apocrine gland
    ºÎºÐºÐºñ»ù, ¾ÆÆ÷Å©¸°»ù
  • apocrine gland carcinoma
    ¾ÆÆ÷Å©¸°¶¡»ù¾ÏÁ¾
  • aporcrine sweat gland
    ºÎºÐºÐºñ¶¡»ù, ¾ÆÆ÷Å©¸°¶¡»ù
  • areolar gland
    Á¥²ÉÆÇ»ù
  • arytenoid gland
    ¸ð»Ô»ù
  • Bartholin gland
    (¢¡greater vestibular gland) Å«¾î±Í»ù
  • bronchial gland
    ±â°üÁö»ù
  • Brunner¡¯s gland
    (¢¡duodenal gland) »ùâÀÚ»ù
  • buccal gland
    º¼»ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pineal recess
    ¼Û°úüÇÔ¿ä(¡­ùèèê).
  • pineal recess
    ¼Û°úü¿À¸ñ
  • pineal recess
    ¼Û°úüÇÔ¿ä(¡­ùèèê).
  • pineal tumor
    ¼Û°úüÁ¾¾ç(¡­ðþåË).
  • pineal tumor
    ¼Û°úüÁ¾¾ç(áæÍýô÷ðþåË)
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • quiescent cell, Q cell
    Á¤Áö¼¼Æ÷
  • Fordyce gland
    Æ÷´ÙÀ̽º¼±
  • Haversian gland
    ÇϹö½º»ù.
  • Haversian gland
    ÇϹö½º »ù.
  • Henle s gland
    Çî·¹¼±.
  • Intestinal gland [Crypt of Lieberkuhn]
    âÀÚ»ù[âÀÚ¿ò]
  • Krause gland
    Å©¶ó¿ìÁ¦»ù,Å©¶ó¿ìÁ¦¼±
  • Meibomian gland
    ¸¶À̺½¼±
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endocrine cell
    ³»ºÐºñ¼¼Æ÷
  • endocrine cell cluster
    ³»ºÐºñ¼¼Æ÷¹«¸®
  • endocrine cell tumor
    ³»ºÐºñ ¼¼Æ÷ Á¾¾ç(¡­ðþåË)
  • gastrointestinal endocrine cell
    À§Ã¢ÀÚ³»ºÐºñ¼¼Æ÷
  • medullary endocrine cell
    ¼ÓÁú³»ºÐºñ¼¼Æ÷
  • pancreatic endocrine cell
    ÀÌÀÚ³»ºÐºñ¼¼Æ÷
  • pineal body
    ¼Û°úü(áæÍýô÷).
  • pineal body
    ¼Û°úü(áæÍýô÷).
  • pineal bud
    ¼Û°úü½Ï
  • pineal calcification
    ¼Û°úü¼®È¸È­(áæÍýô÷à´üéûù).
  • pineal calcification
    ¼Û°úü¼®È¸È­(áæÍýô÷à´üéûù)
  • pineal recess
    ¼Û°úüÇÔ¿ä(¡­ùèèê).
  • pineal recess
    ¼Û°úüÇÔ¿ä(¡­ùèèê).
  • pineal recess
    ¼Û°úü¿À¸ñ
  • pineal tumor
    ¼Û°úüÁ¾¾ç(¡­ðþåË).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Secretory cell of lacrimal gland
    ´«¹°¼¼Æ÷
    [¿¾ ¿ë¾î] ´©¼±¼¼Æ÷
  • Cell of parathyroid gland
    ºÎ°©»ó»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÎ°©»ó¼±¼¼Æ÷
  • Secretory cell of pyloric gland
    À§³¯¹®»ù¼¼Æ÷
    [¿¾ ¿ë¾î] À¯¹®¼±¼¼Æ÷
  • Secretory cell of cardiac gland
    À§µé¹®»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐ¹®¼±¼¼Æ÷
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷(Á¦1Çü»ç±¸¼¼Æ÷)
  • Clear cell [Epinephrine cell]
    ¹àÀº¼¼Æ÷ [¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¸í¼¼Æ÷(¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Sustentacular cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
  • Secretory epithelial cell [Glandular cell]
    ºÐºñ»óÇǼ¼Æ÷ [»ù¼¼Æ÷]
    [¿¾ ¿ë¾î] ºÐºñ»óÇǼ¼Æ÷
  • Interstitial cell [Dark cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Interstitial cell [Leydig`s cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Bronchiolar cell [Clara cell]
    ¼¼±â°üÁö¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐºñ¼¼Æ÷
  • Parafollicular cell [Calcitonin cell]
    ¼ÒÆ÷°ç¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÆ÷¹æ¼¼Æ÷
  • Neurolemmal cell [Schwann`s cell]
    ½Å°æÁý¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æÃʼ¼Æ÷
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • argentaffin cell
    ¾Æ¸£Á¨Å¸ÇÉ ¼¼Æ÷(á¬øà)
  • autosynthetic cell
    ÀÚ°¡ÇÕ¼º¼¼Æ÷ (í»Ê«ùêà÷á¬øà)
  • barrier layer cell
    À庮Ãþ(î¡Ûúöµ) ¼¼Æ÷(á¬øà)
  • B cell
    B ¼¼Æ÷(á¬øà)
  • cell adhesion
    ¼¼Æ÷ºÎÂø(á¬øàÜõó·)
  • cell adhesion molecule
    ¼¼Æ÷ºÎÂøºÐÀÚ(á¬øàÜõó·ÝÂí­)
  • cell affinity
    ¼¼Æ÷ģȭ(á¬øàöÑûú)
  • cell blotting
    ¼¼Æ÷(á¬øà) ºí·ÔÆÃ
  • cell cloning
    ¼¼Æ÷(á¬øà) Ŭ·Î´×
  • cell coat
    ¼¼Æ÷(á¬øà)²®Áú
  • cell cycle
    ¼¼Æ÷ÁÖ±â(á¬øàñÎÑ¢)
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(á¬øàÝÂûù)
  • cell envelope
    ¼¼Æ÷(á¬øà)½Î°³
  • cell factor
    ¼¼Æ÷ÀÎÀÚ(á¬øàì×í­)
  • cell fractionation
    ¼¼Æ÷ºÐȹȭ(á¬øàÝÂüñûù)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pituitary gland
    ³úÇϼöü
  • prostate gland
    Àü¸²»ù, Àü¸³¼±
  • salivary gland
    ħ»ù, Ÿ¾×¼±
  • sublingual gland
    Çô¹Ø»ù, ¼³Çϼ±
  • submandibular gland
    Åιػù, ¾ÇÇϼ±
  • thyroid gland
    °©»ó»ù, °©»ó¼±
  • vitelline gland
    ³­È²»ù
  • acinar cell
    Æ÷»ó¼¼Æ÷
  • air cell
    ÇԱ⵿
  • alveolar cell carcinoma
    ÆóÆ÷¼¼Æ÷¾ÏÁ¾
  • basal cell carcinoma
    ±âÀú¼¼Æ÷¾ÏÁ¾
  • blast cell
    ¸ð¼¼Æ÷
  • blood cell
    Ç÷±¸
  • cell
    ¼¼Æ÷, ¹úÁý, ºÀ¼Ò, °ÇÀüÁö
  • chromaffin cell
    Å©·Òģȭ¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
GC ganglion cell; gas chromatography; general circulation; general closure; general condition; generali...
MEDAC Syndrome Multiple-Endocrine Deficiency Autoimmune-Candidiasis
AEP acute edematous pancreatitis; artificial endocrine pancreas; auditory evoked potential; average evok...
AES acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EP Endocrine-paracrine
MEA Multiple Endocrine Adenomatosis
MEN Multiple Endocrine Neoplasia
MEN I Multiple Endocrine Neoplasia
MEN 1 Multiple Endocrine Neoplasia Type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acinar gland
    Æ÷»ó ¼±
  • adrenal gland
    ºÎ½Å, ºÎ½Å ¼±
    °¢ ½ÅÀå µÎÃø±Ø¿¡¼­ º¹¸· ÈÄ Á¶Á÷¿¡ À§Ä¡ÇÑ ÆíÆòÇÑ ¼Òü. Àΰ£ÀÇ °æ¿ì ÇÇÁú°ú ¼öÁúÀÇ µÎ ±â°üÀÌ À¶ÇյǾî Çü¼ºµÈ´Ù.
  • albarran's gland
    ¾Ë¹Ù¶õ ¼±
  • anterior lingual gland
    Àü¼³¼±, Çô¾Õ»ù
    Çô³¡ ºÎºÐ ±Ùó, Áß¾Ó¼±ÀÇ ¾çÃø¿¡ À§Ä¡Çϴµ¥ ¾ÕºÎºÐÀº Àå¾× Á¡¾× ¼¼Æ÷·Î µÈ ºÐºñ ¼Ò°üÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç µÞºÎºÐÀº Á¡¾× ¼¼Æ÷¿Í ±× ¸Í´Ü¿¡ Àå¾× Á¡¾×¼º ¼¼Æ÷ÀÇ ¾ãÀº ¹Ý´ÞÀ» ÇÔÀ¯Çϴ ȥÇÕ ºÐÁö ¼Ò°üÀ¸·Î µÇ¾î ÀÖ´Ù.
  • apocrine gland
    ¾ÆÆ÷Å©¸°¼±, ºÎºÐ ºÐºñ»ù
    ºÐºñ¹°ÀÌ ¼¼Æ÷ ÀÚÀ¯¸é ÂÊ¿¡ ÀúÀåµÈ ÈÄ ¼¼Æ÷ÁúÀÇ ÀÏºÎ¿Í ÇÔ²² ¹æÃâµÈ´Ù.
  • apocrine sweat gland
    ¾ÆÆ÷Å©¸° ÇѼ±
  • Bowman's gland
    º¸¿ì¸¸¾¾ ¼±
  • bud of palpebral gland
    ´«²¨Ç®»ù ½Ï
  • bud of submandibular gland
    Åιػù ½Ï
  • buds of prostatic gland
    Àü¸³»ù ½Ï
  • circumanal gland
    Ç×¹® ÁÖÀ§ »ù
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • Cowper's gland
    ¿äµµ¸Á¿ï »ù
    µ¿ÀǾî=bulbourethral gland. ¿äµµÀÇ °Ý¸· ºÎºÐ µÚÂÊ °áÇÕÁ¶Á÷¿¡ ¹¯Çô ÀÖ´Â Äá ¸¸ÇÑ ÇÑ ½ÖÀÇ º¹ÇÕ °ü Æ÷»ó »ùÀ¸·Î¼­, ±ä µµ°üÀ¸·Î ¿äµµ¿¡ ¿¬°áµÈ´Ù.
  • cutaneous gland
    ÇǺΠ¼±
  • cystogenous gland
    Çdz¶ ¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
multiple endocrine deficiency syndrome <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis.
Synonym: multiple glandular deficiency syndrome.
(05 Mar 2000)
multiple endocrine neoplasia (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour.
(type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
Origin: Gr. Plassein = to form
(27 Sep 1997)
multiple endocrine neoplasia 1 <radiology> Multiple endrocrine neoplasia syndrome three P's.
Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH
pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression
Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%).
Synonym: Wermer syndrome
(12 Dec 1998)
multiple endocrine neoplasia 2 <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia
Synonym: Sipple syndrome
(12 Dec 1998)
multiple endocrine neoplasia 3 <radiology> Multiple endocrine neoplasia syndrome (type 2B, type 3), medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus (Cf: Marfan syndrome), mucosal neuromas, neurofibromas, ganglioneuromatosis coli More info: MEN syndrome 2B
Synonym: Schimke, marfanoid syndrome
(12 Dec 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
neoplastic endocrine-like syndromes Endocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues. They are often the first indication of a previously undetected neoplasm.
(12 Dec 1998)
diagnostic techniques, endocrine Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes.
(12 Dec 1998)
endocrine Pertaining to internal secretions, hormonal.
Compare: exocrine.
Origin: Gr. Krinein = to separate
(18 Nov 1997)
endocrine cells of gut Cells found throughout the lining of the gastrointestinal tract that contain regulatory peptide hormones and/or biogenic amines. The substances are located in secretory granules and act in an endocrine or paracrine manner. Some of these substances are also found in neurons in the gut. There are at least 15 different types of endocrine cells of the gut. Some take up amine precursors and have been called apud cells. However, most endocrine cells of the gut apparently have endodermal rather than neuroectodermal origin, so the relationship with apud cells is not clear.
(12 Dec 1998)
endocrine disorders Disorders which involve the over-production or under-production of hormone substances from an endocrine gland. Some examples include diabetes, hypothyroidism, hyperthyroidism, hyperparathyroidism, Cushing's disease, Cushing's syndrome and acromegaly.
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain cell
    ³ú½Å°æ¼¼Æ÷
  • cadmium cell
    Ä«µå¹Å ÀüÁö
  • cell
    ÀÛÀº¹æ;¾ÏÀÚ(¼öµµ¿ø ºÎ¼ÓÀÇ);»ç½Ç;¿ÀµÎ¸·Áý;¹«´ý;(±³µµ¼ÒÀÇ)µ¶¹æ;(¹úÁýÀÇ)±¸¸Û;²É°¡·çÁÖ¸Ó´Ï;ÀüÁö;¼¼Æ÷;(Á¶Á÷³»ÀÇ)ÀÛÀº °øµ¿;¼¼Æ÷(°ø»ê´ç µîÀÇ);°¡½ºÅë(±â±¸ÀÇ);ºñÆ®ÀÇ ±â¾ï¼ÒÀÚ;µ¶¹æ»ìÀÌÇÏ´Ù;ÀÛÀº ¹æ¿¡ Ʋ¾î¹ÚÈ÷´Ù
  • cell body
    ¼¼Æ÷ÀÇ
  • cell cycle
    ¼¼Æ÷ÁÖ±â;ºÐ¿­ÁÖ±â
  • cell division
    ¼¼Æ÷ºÐ¿­
  • cell fusion
    ¼¼Æ÷À¶ÇÕ
  • cell lysis
    ¼¼Æ÷¿ëÇØ
  • cell membrane
    ¼¼Æ÷¸·;¿øÇüÁú¸·;=CELL WALL
  • cell sorter
    ¼¼Æ÷ ºÐº°±â
  • cell therapy
    ¼¼Æ÷¿ä¹ý(¾çÀÇ °«³­»õ³¢ÀÇ ¼¼Æ÷¸¦ ÁÖÀÔÇϴ ȸÃá¹ý ('
  • cell wall
    ¼¼Æ÷º®
  • cell-mediated immunity
    ¼¼Æ÷(¸Å°³)¼º ¸é¿ª(¼¼Æ÷¸·¿¡ ºÎÂøÇÏ´Â Ç×üÀÇ Á߻꿡 ÀÇÇÑ
  • closed-cell
    µ¶¸³±âÆ÷ÀÇ;¹ÐÆó±âÆ÷ÀÇ(¼ÒÀç´Â ÇÃ¶ó½ºÆ½µî)
  • complementary cell
    º¸Á· ¼¼Æ÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á